Antigrippin can now produce all

The company "Natur product" before that time, producing and supplying to the market of the Russian Federation its medicinal product under the trade mark Antigrippin has lost the right to this exclusive name. All because of the lawsuit filed by the Federal Antimonopoly Service (FAS), which demanded that the registration of this trademark be recognized as unfair competition from November 2011. And recently, the last session of the cassation instance took place, which recognized the validity of the FAS. After all, in fact it is the exploitation of a stable expression or speaking in legal terms of the well-known, that is, "anti-flu in" - against influenza.

You can congratulate the company "AnviLab" which thus pushed itself the right to produce similar products for the name of the flu against Antigrippin-Anvi and Antigrippin-Maximum. I felt and described these similar drugs (against a set of active substances and their therapeutic effects) against the symptoms of influenza in one annotation prepared for the drug Antigrippin.

Although in Russia everything is possible and obvious today may again become unobvious tomorrow, as the interests of one company are infringed and it is unlikely to leave controlling authorities alone, considering that this symptomatic product against cold and flu was justified as a single Antigrippin, without any additions of competitors Anvi or Maximum). Even in Belarus, the same product was supplied under the brand name Antigrinpin, so as not to mix brands and names.

So let's see whose interest is more obvious, and the wallet is thicker